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Background: The DNA methylation profiles of mammalian cell lines differ from those of the primary tissues from
which they were derived, exhibiting increasing divergence from the in vivo methylation profile with extended time
in culture. Few studies have directly examined the initial epigenetic and transcriptional consequences of adaptation
of primary mammalian cells to culture, and the potential mechanisms through which this epigenetic dysregulation
occurs is unknown.
Results: We demonstrate that adaptation of mouse embryonic fibroblasts to cell culture results in a rapid
reprogramming of epigenetic and transcriptional states. We observed global 5-hydroxymethylcytosine (5hmC)
erasure within three days of culture initiation. Loss of genic 5hmC was independent of global 5-methylcytosine
(5mC) levels and could be partially rescued by addition of vitamin C. Significantly, 5hmC loss was not linked to
concomitant changes in transcription. Discrete promoter-specific gains of 5mC were also observed within seven
days of culture initiation. Against this background of global 5hmC loss we identified a handful of developmentally
important genes that maintained their 5hmC profile in culture, including the imprinted loci Gnas and H19. Similar
outcomes were identified in the adaption of CD4+ T cells to culture.
Conclusions: We report a dramatic and novel consequence of adaptation of mammalian cells to culture in which
global loss of 5hmC occurs, suggesting rapid concomitant loss of methylcytosine dioxygenase activity. The
observed epigenetic and transcriptional re-programming occurs much earlier than previously assumed, and has
significant implications for the use of cell lines as faithful mimics of in vivo epigenetic and physiological processes.Background
DNA methylation in mammals involves attachment of a
methyl group to a cytosine, usually in the context of a CpG
dinucleotide, by a member of the DNA methyltransferase
(DNMT) family of enzymes to yield 5-methylcytosine
(5mC) [1]. The ability to establish and maintain DNA
methylation patterns is essential for normal development
in mammals [2]. The discovery of substantial amounts
of 5-hydroxymethylcytosine (5hmC) in many mammalian
tissues together with the identification of the ten-eleven* Correspondence: Richard.Meehan@igmm.ed.ac.uk
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unless otherwise stated.translocation enzymes (TET1/2/3) that catalyze the
conversion of 5mC to 5hmC have proved key to reveal-
ing a potential mechanism of ‘active’ (enzymatic) DNA
demethylation in mammals. Currently, a ‘sequential oxi-
dation’ model of active DNA demethylation is proposed,
whereby a TET enzyme sequentially oxidizes 5hmC to
5-formylcytosine (5fC) and/or 5-carboxylcytosine (5caC)
[3]; the latter two modified bases can be removed by the
mammalian thymine DNA glycosylase and subsequently
repaired to yield unmodified cytosine [4]. Alternatively, as
DNMT1, a maintenance DNMT, does not recognize and
re-methylate hemi-hydroxymethylated DNA generated
during DNA replication, 5hmC may also be lost by
replication-dependent dilution [5,6]. Interestingly, in
some tissues, UHRF1 may direct DNMT1 to sites ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tenance of 5hmC patterns through cell division, although
the evidence for this mechanism is currently inconclusive
[1,7-9]. The discovery of TET/5hmC-mediated DNA de-
methylation pathways has transformed the view of DNA
methylation in mammals from an inflexible and per-
manent repressive mark to that of a potentially dynamic,
responsive and reversible process [6,8].
DNA methylation at a set of CpG island (CGI) pro-
moters in transformed cell lines differs from that in the
parental tissue of origin, exemplified by an increase in CGI
methylation with immortalization and passage number
[7,10-12]. Such de novo hypermethylation events are far
less common in non-transformed primary cell lines, sug-
gesting that such changes are associated with escape from
replicative senescence in immortalized cells [10,13]. In a
seminal study, Meissner and colleagues [14] used massively
parallel reduced-representation bisulfite sequencing to
show that astrocytes derived from in vivo neural progenitor
cells displayed significantly less de novo promoter methyla-
tion than those derived in vitro from embryonic stem (ES)
cells, and that the number of hypermethylated CGI pro-
moters increased with passage number. Stable methylation
at promoters also distinguished epiblast stem cells cultured
ex vivo from early passage in vivo-derived epiblasts. Altered
patterns of DNA methylation are established within a few
days during in vitro outgrowth of the epiblast [15]. The ori-
gin of these culture-induced DNA methylation changes is
unknown. De novo methylation events in culture may
result from increased activity or inappropriate targeting
of the methyltransferases DNMT3A/B or from loss of a
DNA demethylase activity. In agreement with their
proposed ‘demethylation’ role, mutations in TET1 and
TET2, which are frequent in many cancers, are associated
with a hypermethylated promoter phenotype (as seen in
acute myeloid leukemia), as are ‘de novo’ mutations in
the IDH1/2 genes that result in the production of
2-hydroxyglutarate instead of α-ketoglutarate, a competi-
tive inhibitor of TET enzyme activity [6]. Over 20 years
ago, Antequera, Boyes and Bird suggested that the
observed de novo methylation of CGI promoters in trans-
formed cells may result from loss of a demethylase activity
in culture [11].
We have previously noted that many transformed cell
lines possess substantially less absolute 5hmC levels com-
pared with their tissues of origin [16]. Similar changes in
global 5mC levels have not been observed [17-20]. As the
relative levels of global 5hmC in cell lines do not correlate
with those observed in the normal tissues of origin, we
hypothesized that the low levels of global 5hmC in
transformed cell lines reflected loss of a TET-associated
methylcytosine dioxygenase activity upon adaptation of
cells to culture. Here, we investigated the effect of cul-
ture adaptation on the methylome, hydroxymethylomeand transcriptome of mouse embryonic fibroblasts (MEFs).
We present evidence of rapid and genome-wide epigenetic
and transcriptional remodeling of mammalian cell states
in culture. Our results reveal an underappreciated differ-
ence between the epigenetic character of mammalian tis-
sues and primary cell lines derived therefrom, and raise
potential reservations about the use of such systems as
faithful models of in vivo DNA methylation dynamics.Results
Rapid, global loss of 5hmC, but not 5mC, occurs during
adaptation of mammalian cells to culture
To determine the consequences of adaptation to culture
on the mammalian methylome we purified genomic
DNAs from primary MEFs (embryonic day (E)13.5 post
coitum) and subsequently derived cultured MEFs at vari-
ous time-points (3, 7 and 9 days after isolation). Each ex-
periment consisted of MEF cells pooled from three to
five embryos of mixed gender. The relative global 5hmC
content of each sample was then determined by immuno
dot-blot [16]. A rapid and progressive loss of 5hmC was
observed upon adaptation of MEFs to standard culture
conditions (Figure 1a). Quantification of spot intensity
by densitometric analysis of four biological replicates re-
vealed a 60% loss of global 5hmC by passage 1 (7 to 9 days
in culture; P < 0.05; Figure 1b). In contrast, quantification
of total modified cytosine (5mC + 5hmC) levels by lumi-
nometric methylation analysis (LUMA) revealed a small
(4 to 8%) decrease in total modified cytosine in cultured
cells (Figure 1c). The modest reduction in total modified
cytosine is entirely consistent with 1) the substantial loss
of 5hmC observed, as 5hmC constitutes between 0.1 and
7% of modified cytosine in non-central nervous system
mouse tissues, and 2) little or no change in global 5mC
levels [21]. Thus, a significant and rapid loss of 5hmC is
observed upon adaptation of MEF cells to culture, which
does not translate into a substantial global loss or gain of
5mC. Finally, loss of 5hmC was confirmed at the single
cell level by co-staining of cells with 5mC and 5hmC anti-
bodies during adaptation to culture (Figure 1d). In MEF
tissue and cultured MEFs (P0, P1 and P2 the 5mC anti-
body detects bright spots that are coincident with
DAPI-positive centromeric heterochromatin (Figure 1d).
In contrast, the 5hmC antibody does not stain DAPI-
positive centromeric heterochromatin in MEF tissue but
instead occupies 5mC-low staining regions that are con-
sistent with 5hmC’s reported euchromatic localization in
ES cells [22]. The merged image illustrates 5mC/5hmC
counter-staining in MEF tissue (Figure 1d). In agreement
with the dot-blot analysis, detection of 5hmC by immuno-
fluorescence is reduced to the extent of being undetect-
able under the conditions used in P0, P1 and P2 MEFs
(Figure 1d and data not shown).
Figure 1 (See legend on next page.)
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Figure 1 Adaptation of mammalian cells to standard culture conditions results in 5hmC loss. (a) Dot-blot of genomic DNA from primary
MEF tissue and cultured cells derived therefrom with a 5hmC-specific antibody (500 ng were loaded in all lanes). ssDNA, single-stranded DNA. (b)
Quantification of global 5hmC levels by densitometric analysis of dot-blots (±SE). P, passage. (c) Quantification of total (5hmC + 5mC) modification
levels in DNA by LUMA. DNA from triple knock-out (dnmt3a-/-, dnmt3b-/-, dnmt1-/-) mouse ES cells (TKO) which contain <2% DNA methylation
was used as a negative control and was set to a value of 0 and DNA methylation levels in MEF tissue were set to 100. Dnmt1-/- MEF DNA (MEF DN ),
which contains approximately 20% of normal methylation levels, is also shown (±SE). (d). Fluorescence microscopy images of MEFs during adaptation
to culture stained with antibodies against 5mC (green) and 5hmC (red). DNA was counterstained with DAPI (blue). A merged 5mC/5hmC image is
shown on the top right while two overexposed 5hmC-only images below show no nuclear staining after culture. (e) Bar-chart of quantitative RT-PCR
showing reduced expression of Tet1 upon adaptation to culture. Values are the average of three biological replicates normalized to Gapdh expression
± standard deviation. *P < 0.05, Mann-Whitney U-test. (f) Dot-blot of DNA (1 μg) from male and female primary MEFs showing partial rescue of global
5hmC levels by addition of vitamin C (1,000 μM). Top row shows partial recovery of global 5hmC after addition of vitamin C at passage 2. Bottom
row shows reduction of 5hmC loss after addition of vitamin C at passage 1. (g) Dot-blot of DNA (500 ng) from naïve CD4+ T cells and cultured
cells derived therefrom with a 5hmC-specific antibody. Two replicate experiments are shown. (h) Quantification of global 5hmC levels by densi-
tometric analysis of dot-blots shown in (g). Values were normalized to a methylene blue loading control.
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DNA methylation cycle revealed a gradual reduction in
Tet gene expression in culture, with Tet1 showing a
significant decrease in expression compared with
primary MEF tissue (Figure 1e). Thus, loss of 5hmC may,
in part, be due to loss of Tet enzyme levels in cultured
cells. However, it is unlikely that the substantial global
loss of 5hmC in culture can be wholly explained in terms
of the reductions in Tet gene expression levels reported
here. DNA replication would be required for passive loss
of 5hmC; thus, any increase in proliferation rate in
culture in combination with reduced levels of Tet
enzymes would accelerate the observed loss of 5hmC.
Several recent studies have also reported that addition of
vitamin C, a co-factor in Tet-mediated conversion of
5mC to 5hmC, results in increased Tet enzymatic activ-
ity and global 5hmC content in mouse ES cells and MEFs
[23,24]. Thus, the loss of global 5hmC observed upon
adaptation of MEFs to culture may also result from
absence of vitamin C, which was not present in the
culture media used. Addition of vitamin C to the culture
medium during MEF establishment resulted in partial
recovery of global 5hmC levels (Figure 1f ). This is
entirely consistent with the observed reduction of Tet
expression (Figure 1e); although vitamin C increases Tet
enzymatic activity and consequently 5hmC content,
insufficient Tet1 enzyme is present in the cultured cells
to generate the 5hmC levels observed in the MEF tissue
(Figure 1f ).
To confirm our observation in an unrelated tissue, naïve
CD4+ T cells were isolated from two wild-type mouse
spleens by magnetic activated cell-sorting (MACS) and cul-
tured under standard stimulating conditions (anti-CD3 and
anti-CD28 ± IL-2) for five days. The proliferation of stimu-
lated Tcells in culture was confirmed by carboxyfluorescein
diacetate succinimidyl ester staining (CFSE, Figure S1a in
Additional file 1) and cell cycle staging was assessed by pro-
pridium iodide staining (Figure S1b in Additional file 1). In
complete agreement with the observations made duringadaptation of MEFs to cell culture, a substantial reduction
(more than five-fold) in global 5hmC levels was observed
in proliferating CD4+ T cells after three days of culture
(Figure 1g,h).
Loss of 5hmC in a pure CD4+ T-cell population sug-
gested that changes in tissue heterogeneity did not con-
tribute to the global loss of 5hmC in culture. To exclude
changes in population substructure as a contributing fac-
tor to the observed 5hmC loss during MEF establishment,
we used both transcriptome profiling and immunohisto-
chemistry. Using published data sets of gene expression in
90 different mouse tissues and cell lines, we identified
MEF-specific genes that are a signature of its cellular iden-
tity [25] (Gene Expression Omnibus (GEO) ID GSE1133).
We identified 20 MEF-specific genes that 1) were most
highly expressed in MEFs and 2) whose expression in
MEFs was at least two-fold higher than that in any other
tissue (Table S1 and Figure S2a in Additional file 1). The
majority of the MEF-specific gene set (12/20) showed no
reduction in expression between the tissue and cultured
MEFs (Figure S2b in Additional file 1), consistent with
the tissues having the same cellular identity and origin.
The remaining MEF signature genes (8/20) were highly
expressed, but to differing extents, in both sets of sam-
ples, which may be due to adaptation to culture. This
implies that the heterogeneity index of the ‘tissue’ sam-
ple is low and it is not highly contaminated with non-
MEF cells. In addition, we performed immunostaining
of primary embryonic fibroblast preps before and after
1 week in culture with the MEF-specific marker, Arid5b
(Figure S2a in Additional file 1). Arid5b staining was
equivalent in both tissue and cultured populations
(Figure S2c in Additional file 1). Significantly, we ob-
served no obviously negative staining cells in either the
tissue or cultured samples, suggesting that selection of
a subpopulation of cells in culture is not a contributory
factor to the observed global loss of 5hmC. Taken to-
gether, these observations, in combination with the overall
stability of the 5mC profiles, implies that the primary
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origin but have acquired altered epigenetic signatures.Cell culture-induced 5hmC loss occurs genome-wide and
independent of 5mC levels
The conspicuous loss of global 5hmC observed between
primary tissues and their matched cultured cells could
reflect genome-wide loss of 5hmC or loss from distinct
genomic compartments (that is, repetitive elements,
gene-bodies or promoters,) or chromosomes (that is,
the inactive X chromosome). To address this, we used a
combination of immunoprecipitation and genome-wide
tiling microarrays (hMe- and Me-DIP-chip) to deter-
mine both the 5hmC and 5mC profiles of four male and
female (Nmale = 2, Nfemale =2) primary E13.5 MEF tissues
and cultured cells derived from the same four samples
(Nmale = 2, Nfemale = 2) after 7 days in culture (Figure 2).
MEF establishment was chosen as the model system to
study genome-wide changes in 5hmC patterns as MEFs
possess substantially higher levels of 5hmC compared
with naïve CD4+ T cells (Figure S1c in Additional file
1), enabling more sensitive detection of changes in
5mC and 5hmC by Me- and hMe-DIP assays. An early
passage (Figure 2a) was assayed in order to identify
early epigenetic changes, and to minimize the effects
of prolonged culture and replicative senescence. All
male and female replicate MEFs showed marked ap-
proximately 10-fold (Mann-Whitney U-test, P = 0.028)
loss of 5hmC after 7 days in culture as determined by
dot-blot (Figure 2a, right panel). As both genic and
non-genic regions of the mouse genome have been
shown to possess 5hmC, we used tiling microarrays
covering all of chromosomes 14 to 19, and both sex chro-
mosomes (X and Y). The features represented on each
array are listed in Table S2 in Additional file 1.
The sensitivity of our experimental approach was dem-
onstrated by the ability to detect locus-specific, allele-
specific increases in DNA methylation at gene promoters
in female cells previously reported to undergo promoter
hypermethylation on the inactive X chromosome (Xi) as
part of the dosage compensation mechanism (Figure S3a
in Additional file 1). Conversely, the promoter of the
Xist gene, which is expressed and unmethylated only
on the Xi, showed the expected increase of 5mC in
male (Xa) versus female cells (Xa, Xi) (Figure S3b in
Additional file 1). The X chromosome profile in female
cells had significantly reduced levels of both 5mC and
5hmC compared with the male X chromosome profile
(Figure S3c in Additional file 1). As male cells possess
a single active X chromosome (Xa), the reduced 5mC
levels observed across the female X chromosome profile
suggest genome-wide hypomethylation on the Xi, consistent
with several previous reports [26-29].To gain an overview of genome-wide modification
changes upon adaptation to culture, chromosomes were
divided into 2 Mb windows and the median modification
content of each region determined. Both the pattern and
levels of genome-wide enrichment of 5mC are maintained
upon adaptation of MEFs to culture (Figures 2b,c). Auto-
correlation analysis of all probes on the array revealed that
concordance between neighboring 5mC probes was simi-
lar in both tissue and culture samples, consistent with un-
changed levels of 5mC, and thus signal-to-noise ratios, in
both conditions (Figure 2d). Thus, the genome-wide pro-
file of 5mC in primary MEFs after 7 days in culture is
largely unaltered from that of the tissue of origin. The
genome-wide conservation of 5mC patterns between pri-
mary MEF tissues and their cultured counterparts also
suggests that no major changes in cell composition have
occurred in the cultured cells.
In complete contrast to the 5mC profile, the presence
of 5hmC was significantly reduced and the correspond-
ing profile dramatically altered in MEFs in culture com-
pared with primary cells; the clear patterning of 5hmC
observed for MEF tissue is lost in the matched cultured
samples for both male and female cells (Figures 2e,f ).
Autocorrelation analysis confirmed the reduction in con-
cordance between neighboring 5hmC probes in culture
(Figure 2g). The higher noise-to-signal ratio in 5hmC
profiles of cultured samples was consistent with a global
reduction of 5hmC in those samples. As expected, un-
supervised hierarchical clustering grouped the 5mC
samples by sex, reflecting 5mC differences on the X
chromosome between samples, whereas 5hmC samples
clustered by sample history (tissue versus culture; Figure
S4 in Additional file 1), reflecting the substantial change
in the 5hmC profile upon of adaptation of MEFs to cul-
ture. A representative portion of chromosome 14 illus-
trates the striking change in 5hmC profile induced by
culture (Figure 2h). In tissue, both 5mC and 5hmC show
similar distributions and are enriched in gene-rich re-
gions. The 5mC profile is largely unchanged before and
after culture, with domains of enrichment and depletion
clearly conserved in both conditions (Figure 2h, left
panel). In contrast, the 5hmC profile is substantially al-
tered in culture (Figure 2h, right panel), with regions of
enrichment and depletion less discernible against a
higher level of background noise, consistent with sub-
stantial loss of 5hmC in culture reported here. This
change in 5hmC profile was highly similar in all four
biological replicates (Figure S5 in Additional file 1).
We next identified peaks of 5hmC enrichment, defined
as any five consecutive probes in which a minimum of
four probes had an enrichment score above the 90th
percentile, yielding a false discovery rate <0.01. Probes
within peaks are henceforth referred to as ‘peak probes’.
Significantly less 5hmC peak probes were detected in
b. 5mC c. 5mC





Figure 2 Cell culture-induced 5hmC loss occurs genome-wide and does not reflect changes in 5mC. (a) Dot-blot of genomic DNA (500 ng)
from MEF primary tissue and cultured cells derived therefrom with a 5hmC-specific antibody (left). Quantification of global 5hmC levels by densitometric
analysis of dot-blots (right). 5hmC values were normalized to the single-stranded DNA (ssDNA) loading control. *P < 0.05, Mann-Whitney U-test.
(b) Heatmap showing median 5mC enrichment levels in non-overlapping 2 Mb windows of the mouse genome (chromosomes 14 to 19 and X)
from primary MEF tissue and cultured cells derived therefrom, as determined by MeDIP-chip. (c) 5mC-enrichment was highly correlated between
MEF tissue and matched cultured cells derived therefrom (Spearman’s rho = 0.98, P < 0.00001). A scatterplot of 5mC enrichment in male
replicate ‘A’ before and after cell culture. (d) Autocorrelation analysis of 5mC enrichment of all probes (2.1 million) on the array. (e) Heatmap
showing median 5hmC enrichment levels in non-overlapping 2 Mb windows of the mouse genome (chromosomes 14 to 19 and X) from primary
MEF tissue and cultured cells derived therefrom, as determined by hMeDIP-chip. (f) A scatterplot of 5hmC enrichment in male replicate ‘A’ before and
after cell culture. (g) Autocorrelation analysis of 5hmC enrichment of all probes (2.1 million) on the array revealed a marked reduction in concordance
between the 5hmC values of adjacent probes for MEF tissue and matched cultured cells derived therefrom. (h) Clear patterning of 5hmC is lost upon
adaptation of MEFs to culture. A schematic representation of the 5mC (left panel, red) and 5hmC (right panel, blue) array profiles over a 40 Mb section
of chromosome 14; adapted from the UCSC Genome Browser. Refseq transcripts (transcript) mapped to the region are also shown.
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P < 0.01), whereas the number of 5mC peak probes
did not change significantly between tissue DNA and
DNA from cultured cells (Figure S6a in Additional file 1).
The genomic distribution of 5hmC peak probes revealed
enrichment of 5hmC peaks in genic regions, as previously
widely reported (Figure S6b in Additional file 1). Although
broadly similar, the genomic distribution of 5hmC in cul-
ture showed a relative reduction in peak probes from
genic regions, in particular, exons and introns (Figure S6b
in Additional file 1). Interestingly, the number of 5mC
peak probes in gene promoters showed a small but signifi-
cant increase in culture, possibly reflecting discrete pro-
moter hypermethylation events.a. gene body c. promoter
b. gene body - 5hmC loss d. promoter - 5mC gain
Figure 3 Global loss of 5hmC and locus-specific gains in 5mC sugges
showing a significant change (Mann-Whitney U-test, P <0.01) in gene body
culture. (b) Schematic representation of the mean (N = 4) 5hmC content of tw
Bar chart of hMeDIP-qPCR showing decreased gene body 5hmC content in c
replicates ± standard deviation. Multiple primer pairs were used to determine
(black bars). (c) A histogram of the distribution of genes showing a significant
5hmC (blue) content upon adaptation of MEF cells to culture. (d) A schematic
Hoxc-12, -11 and -4 genes before (blue) and after (orange) adaptation to cultu
5mC content at the Hoxc-12, -11 and -4 gene regions in cultured MEFs (lower
deviation. The location of hMeDIP-qPCR primers for each Hoxc region is show
high levels of 5hmC in culture. A schematic representation is shown for
samples (four male (♂) and four female (♀)). The location of hMeDIP-qP
retention of 5mC and 5hmC at the imprinted loci H19 and Gnas (lower p
replicates ± standard deviation.Genome-wide loss of 5hmC and locus-specific gains in
5mC are consistent with loss of methylcytosine
dioxygenase activity in culture
In contrast to 5mC, 5hmC is enriched in euchromatin,
and increased genic 5hmC is broadly associated with
increased transcription levels [6,16,22]. Thus, we next
sought to (a) examine changes in 5hmC at the level of
individual genes and (b) determine the effect of this
change on associated transcript levels. The average 5hmC
levels of 2,727 gene bodies (42% of all genes analyzed)
were significantly altered (Mann-Whitney U-test, P < 0.01,
adjusted for multiple testing) in culture in comparison to
459 gene bodies (7% of all genes analyzed) showing signifi-
cantly changed 5mC levels (Figure 3a). Interestingly, thee. H19 locus (5hmC)
f. imprinted loci
t loss of demethylase activity in culture. (a) Histogram of genes
5mC and 5hmC content upon adaptation of primary MEF cells to
o gene (Klf5 and Vwa2) bodies before and after adaptation to culture.
ultured MEFs (lower panel). Values are the average of four biological
values across gene bodies of Klf5, Vwa2, LRRC30 and 1700054A03Rik
change (Mann-Whitney U-test, P <0.01) in promoter 5mC (red) and
representation of the mean (N = 4) promoter 5mC profiles at the
re (upper panel). Bar chart of hMeDIP-qPCR showing increased promoter
panel). Values are the average of four biological replicates ± standard
n in black above gene maps (top). (e) The imprinted locus, H19, maintains
the 5hmC profile across the imprinted locus, H19, for all eight
CR primers is shown in black. (f) Bar-chart of hMeDIP-qPCR showing
anel) in cultured MEFs. Values are the average of four biological
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contrasting. As expected, 81% of those genes showing
both significant (Mann-Whitney U-test, P < 0.01) and sub-
stantial (top 5% absolute change) changes in genic 5hmC
levels in culture also showed loss of 5hmC. Genes losing
5hmC in culture were not enriched for any functional
categories (P < 0.05) as determined by gene annotation en-
richment analysis (data not shown), consistent with a gen-
eral loss of methylcytosine dioxygenase activity in culture.
We confirmed the loss of 5hmC across the gene body of
several of the top changing genes, including von Willeb-
rand factor A domain containing 2 (Vwa2), Kruppel-like
factor 2 (Klf5), leucine rich repeat containing 30 (Lrrc30)
and a non-coding RNA (1700054A03Rik) by hMeDIP-
qPCR in all eight biological replicates (Figure 3b). The ob-
served loss of 5hmC from individual genes was highly con-
sistent between replicates (Figure S7 in Additional file 1).
In contrast, 85% of those genes showing both significant
(Mann-Whitney U-test, P < 0.01) and substantial (top 5%
absolute fold change) changes in genic 5mC levels in cul-
ture showed gain of 5mC in culture (Figure 3a). Loss of a
demethylase activity has been previously proposed as the
cause of promoter hypermethylation events commonly
observed in transformed cell lines and cancer cells, and in-
hibition of Tet methylcytosine dioxygenase activity is dir-
ectly linked with increased 5mC, while over-expression of
Tet1 leads to global demethylation [11,30]. Focusing on
promoter regions (representing 0.6% of the array), we ob-
served a shift towards gain of 5mC but not 5hmC at gene
promoters in culture (Figure 3c). Although no enrichment
for individual Gene Ontology (GO) terms was observed
for promoters gaining 5mC in culture after correction for
multiple testing, functional annotation clustering of the
GO terms revealed an enrichment for genes involved in
‘pattern specification’ and ‘organ development’ (Table S4
in Additional file 1). The genes underlying these terms
were primarily homeobox genes, including Hoxc4, Hoxc6,
Nkx2-3, Cdx1 and Rax. Indeed, an agglomerative methy-
lation event was evident across the entire HoxC cluster
upon adaptation to culture, with most HoxC genes show-
ing a gain in promoter methylation (Figure 3d; Figure S8
in Additional file 1). Comparative bisulfite sequencing
analysis of the Hoxc4, Hoxc5, Hoxc9, Hoxc11 and Hoxc12
promoters in the tissue and cultured MEF samples is
consistent with gains of 5mC at all promoters tested,
with a median gain of 18% (range: 2.1 to 26%; Figure
S8b in Additional file 1). It is noteworthy that both the
global loss of 5hmC and the gain of promoter-specific
hypermethylation observed here are hallmarks of many
cancers, and loss of a TET-mediated demethylase activ-
ity through mutation or substrate inhibition is being im-
plicated in a growing number of malignancies [31].
Thus, adaptation of mammalian cells to culture may
offer a tractable model system in which to study theinitiation and progression of epigenetic dysfunction upon
loss of a methylcytosine dioxygenase activity.
It has been reported that 5hmC DNA immunoprecipita-
tion can be compromised by the effects of DNA sequence
composition on antibody affinity [32,33]. To confirm that
the observed changes in 5hmC enrichment were inde-
pendent of the enrichment technique, we assayed loci that
increased, decreased or retained 5hmC in culture using
GLIB (glucosylation, periodate oxidation, biotinylation)
enrichment followed by quantitative PCR (qPCR) [34].
The relative enrichment of 5hmC at all tested loci was
almost identical when using either GLIB or hMeDIP en-
richment (Figure S9a,b in Additional file 1). Moreover,
the genome-wide profiles of 5hmC determined here were
highly similar to a recently published whole-genome
5hmC profile of primary MEFs determined by GLIB-seq
(Figure S9c in Additional file 1; Short Read Archive acces-
sion SRX244234) [35].
Intriguingly, against a background of global loss of
5hmC, the imprinted loci, H19 and Gnas, remained
highly enriched for 5hmC in culture (Figure 3e,f ). This
observation mirrors that seen in the developing embryo
where H19 and other imprinted loci are protected from
demethylation, suggesting that 5hmC dynamics at such
loci differ from those in the remainder of the genome
[36]. Similar enrichment patterns were observed
across the H19 and Gnas loci in a recently published
study of 5hmC patterns in cultured MEFs using GLIB-
seq (Figure S9d in Additional file 1) [35]. In agreement
with this observation, during vitamin C induced, Tet-
dependent demethylation of promoters in mouse ES
cells, many imprinted genes, including H19 and Gnas,
remain resistant to demethylation [23].
Whereas the tiling microarrays used here assay 25% of
the mouse genome, they do not represent a complete
genome-wide survey of 5hmC changes in MEFs during
adaptation to culture. To confirm the observed redistri-
bution of 5hmC on a genome-wide scale, we subjected
both input and hMeDIP DNA isolated from MEFs
before and after adaptation to culture to massively paral-
lel sequencing (hMeDIP-Seq). A minimum of 30 million
uniquely mapped reads were obtained for each sample
(Figure S10a in Additional file 1). The results obtained
from this additional biological replicate of MEF estab-
lishment in culture were highly similar to those deter-
mined by array hMeDIP-chip (r = 0.4, P < 1 × 10-16;
Figure S10b in Additional file 1), including loss of 5hmC
from gene bodies (Figure S10c in Additional file 1),
maintenance of 5hmC across the H19 locus (Figure S10d
in Additional file 1) and widespread gains in 5hmC
across the Hoxc cluster (Figure S10e in Additional file 1).
Interestingly, gains in 5hmC were observed across all Hox
clusters, suggesting that these loci are particularly suscep-
tible to epigenetic disruption in culture (Figure S10f in
Nestor et al. Genome Biology  (2015) 16:11 Page 9 of 17Additional file 1). Finally, only 45% of peaks of 5hmC
enrichment observed in tissue were also observed in the
cultured samples, again confirming the genome-wide
redistribution of 5hmC in cultured cells.
Cell culture results in repression of epigenetic processes
Genic 5hmC levels are generally positively associated
with transcriptional activity [6,16]. Thus, we sought to
determine if the observed genome-wide loss of 5hmC
reflected changes in transcription. RNA from the same
samples used for genome-wide 5mC/5hmC profiling
(N = 8; Figure 2a) were labeled and hybridized to Illumina
MouseWG-6 v2.0 gene expression microarrays. Despite
the loss of 5hmC in culture, a positive association with
transcription level was observed in both cultured cells and
MEF tissue (Figure 4a). Principle component analysis of
the gene expression data clearly separated uncultured and
cultured samples; the first principle component (PCA1)
explained approximately 95% of the variation in the datab.
d. e.
a.
Figure 4 Change in cell state accompanies adaptation of cells to cultu
in MEF tissue (blue) and cultured (orange) cells. A gene was classified as expre
Mann-Whitney U-test. (b) Hierarchical clustering of the principle components
culture showing that the transcriptome of cultured MEFs is very different from
and culture samples cluster separately. Adaptation to culture also results in a
(c) Volcano plot showing the widespread, bi-directional changes in gene exp
Red dots indicate genes losing 5hmC in culture; yellow dots indicate genes g
The horizontal dashed line indicates P < 0.01; the vertical dashed lines indicate
up-regulated (P < 0.01, fold-change >1.5) for MEFs in culture. The number of i
Bar chart showing GO term analysis of genes down-regulated (P < 0.01, fold-c
processes. The number of individual genes in each category is shown in whitwhereas PCA2 explained 2.3% of the variation, which
seemed to reflect sample gender (Figure 4b). Thus,
adaptation to culture resulted in an altered transcrip-
tional state that was (i) similar between all four cultured
samples, but (ii) differed markedly from that of the MEF
tissue from which the cultures were derived. The
changes in gene expression induced by adaptation to
culture were widespread, with 7,287 genes identified as
differentially expressed (P < 0.01, paired t-test, adjusted
for multiple testing). The changes in differentially
expressed genes were primarily small (90% changed less
than two-fold) and bi-directional; 3,865 genes signifi-
cantly up-regulated and 3,431 genes down-regulated
(Figure 4c). However, gene expression changes ex-
plained <1% (r2 = 0.009, P = 0.00001) of the variation in
genic 5hmC values between MEF tissue and the cul-
tured cells derived therefrom. Indeed, approximately
40% of genes showing a significant change in genic
5hmC level between MEF tissue and culture were notc.
re. (a) A boxplot showing that 5hmC is enriched in transcribed genes
ssed if its probes had a combined detection P-value <0.01. ***, P < 0.01,
of gene expression microarray data upon adaptation of MEF tissue to
that of the MEF tissue from which they were derived. Tissue samples
reduction in the sex-specific transcriptional differences between samples.
ression observed upon adaptation of MEF tissue to culture conditions.
aining 5hmC in culture; blue dots indicate the 100 most outlying genes.
fold change >1.5. (d) Bar chart showing the GO term analysis of genes
ndividual genes in each category is shown in white. Red line, P = 0.01. (e)
hange >1.5) for MEFs in culture were significantly enriched for epigenetic
e. Red line, P = 0.01. The x-axis values for (d) and (e) are '-log10(P-value)'.
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expression microarray. These findings make the import-
ant point that the observed genome-wide loss of genic
5hmC did not result from a concomitant genome-wide
loss of transcription.
Gene annotation enrichment analysis was used to
identify the functional categories of genes changing
expression upon adaptation to culture. Using strict cri-
teria for definition of differential gene expression (paired
t-test P < 0.01, absolute fold-change >1.5) we found that
up-regulated and down-regulated genes were signifi-
cantly enriched (modified Fisher exact test, P < 0.01, cor-
rected for multiple testing) for different functional
annotations (Figure 4d,e). Genes up-regulated in culture
were enriched for carbohydrate metabolism and cell ad-
hesion genes, possibly reflecting adaptation to growth on
a two-dimensional plastic surface (Figure 4d). However,
a very recent study found that genes belonging to the
categories ‘cell adhesion’ and ‘biological adhesion’ were
also the most significantly down-regulated upon over-
expression of Tet1 during re-programming of MEFs to
induced pluripotent cells, suggesting that these genes are
directly regulated by Tet1 [37]. In striking contrast,
genes down-regulated in culture were highly significantly
enriched (P < 1e-12) for categories linked with chromatin
structure, chromatin re-modeling, and RNA processing
(Figure 4e). Most of these functional categories con-
tained overlapping sets of genes, including methylation-
sensitive DNA binding proteins (Ctcf, Cxxc1, Cxxc4,
Gpbp1), DNA methyltransferases (Dnmt1 and Dnmt3b),
chromatin remodeling enzymes (Smarcad1), histone-
modifying enzymes (Ezh2, Hdac2), and multiple mem-
bers of the histone H1, H2a and H2b gene families.
Interestingly, the Tet1 gene was also significantly down-
regulated (paired t-test, P < 0.01, fold-change = -1.4). Gene
set enrichment analysis confirmed the significance of
PRC2 component (Ezh1, Ezh2, Eed, Suz12 and Rbbp4)
down-regulation in culture (P = 0.002). Numerous recent
studies have revealed extensive crosstalk between DNA
methylation and PRC2, with the appropriate deposition of
each repressive mark being inter-dependent, linking these
two layers of epigenetic regulation [38,39].
Genome-wide redistribution of 5hmC is a general feature
of cell culture
Finally, we sought to determine the generality of the
5hmC redistribution in cultured MEFs by analysis of
previously published whole genome profiles of 5mC and
5hmC in mouse CD4+ T cells undergoing differentiation
in culture (GEO: GSE59212) [40,41]. In a very recent
study, Tsagaratou and colleagues [41] used cytosine-5-
methylenesulfonate (CMS)-DIP to dissect the dynamics
of 5hmC in murine naïve CD4+ T cells and T-helper
cells derived from those cells in vitro. Unlike hMeDIP,the anti-CMS antibody recognizes CMS generated from
5hmC by sodium bisulfite conversion, and exhibits
markedly lower background pull-down and less sequence-
dependent performance than hMeDIP [42]. First, the au-
thors noted a dramatic and rapid loss of global 5hmC in
culture as reported here (Figure 1g). Indeed, the authors
noted that the loss of 5hmC in cultured T-helper cells was
sufficient to preclude reliable locus-specific analysis with
CMS-DIP. On a genome-wide scale, however, the patterns
of 5hmC redistribution in CD4+ T cells (Figure S11a in
Additional file 1) were remarkably similar to those ob-
served in MEFs (Figure 2h). The number of 5hmC-
enriched peaks was reduced seven-fold in culture, with a
significant (χ2; P < 0.001) shift of peaks from genic regions
to inter-genic regions (Figure S11b in Additional file 1),
precisely as seen in MEFs (Figure S6a,b in Additional
file 1). Moreover, the median 5hmC content of gene
bodies reflected this loss (Figure S11c in Additional file 1).
Unlike MEFs, however, CD4+ T-cell promoters showed
a tendency towards 5hmC loss, though on a smaller
scale than that observed for gene bodies (Figure S11d in
Additional file 1).
To study genome-wide changes in 5mC in cultured
CD4+ T cells we analyzed published methyl-binding do-
main (MBD)-Seq data of mouse CD4+ naïve T cells and
their cultured derivatives (GEO: GSE25689) [40]. MBD
affinity purification interrogates methylated CpG-rich
sites across the genome [40]. Whereas gene bodies
showed a modest skew towards 5mC loss in culture,
promoters were skewed towards gain of 5mC in culture,
particularly those promoters undergoing large (greater
than two-fold) gains (Figures S11e,f in Additional file 1).
Thus, the genome-wide redistribution of 5hmC in cul-
tured CD4+ T cells is highly similar to that observed in
MEFs, as is the skew towards gains in promoter methy-
lation (5mC). To further validate these findings we per-
formed h/MeDIP-qPCR at loci gaining and losing 5hmC
and/or 5mC in MEFs and CD4+ T cells. The changes in
5hmC were remarkably similar in CD4+ T cells and
MEFs, in both the direction and scale of change (Figures
S12a,b in Additional file 1). In contrast, 5mC was re-
markably stable in both cell types during culture, in
agreement with our observations in MEFs (Figures
S12c,d in Additional file 1). Finally, we assessed the ef-
fect of vitamin C on 5hmC levels during culture of CD4
+ T cells. The addition of vitamin C resulted in partial or
complete rescue of 5hmC at all loci tested (Figures S12b
in Additional file 1). Significantly, two loci (Hoxc4 and
Gnas) showed two-fold and six-fold increases in 5hmC
compared with uncultured, non-proliferating naïve T
cells, respectively. Thus, the observed increase in 5hmC
induced by vitamin C cannot be due solely to an inhibi-
tory effect on proliferation rate, strongly suggesting in-
creased methyl-cytosine dioxygenase activity.
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A fundamental assumption underlying the use of cul-
tured cells in biological research is that cell lines retain
and mimic the molecular characteristics of the tissue
from which they were derived, allowing observations
made in vitro to be directly translated to an in vivo con-
text. Cell lines have been extensively used to investigate
the normal and pathogenic role of DNA methylation,
particularly its dysregulation in cancer [20]. However,
over 20 years ago, Antequera, Boyes and Bird [11] noted
aberrant de novo CGI methylation at 14 loci in mouse
NIH3T3 and L cells, which was interpreted as cell
culture-induced changes in DNA methylation. Subse-
quently, using restriction landmark genomic scanning, a
comparison of six human ES cell lines derived and cul-
tured in various conditions showed widespread inter-line
differences in DNA methylation, which could be further
altered by changing serum levels in culture [43]. Mouse
ES cells are derived from E3.5 blastocyst cells that are
globally hypomethylated, but once grown in serum they
become hypermethylated [44]. In analogous observation
to our adaptation experiment, there is a massive depos-
ition of DNA methylation during ES cell establishment
in serum [45]. However, cultivating ES cells in the pres-
ence of small molecule inhibitors (2i medium) leads to
reversible global hypomethylation [46]. Molecular ana-
lysis suggests there is a high degree of similarity between
the hypomethylated E3.5 blastocyst cells and 2i ES cells,
as well as between hypermethylated E6.5 blastocyst cells
and serum ES cells [44,47,48]. This demonstrates that
the correct culturing conditions can lead to ‘epigenetic’
equivalence between cells propagated in culture and
their embryo/animal counterparts.
Restriction landmark genomic scanning was also used
to reveal that CGI hypermethylation was 5-fold to 90-
fold more common in cancer cell lines compared with
primary malignancies, and that approximately 60% of
the loci methylated in cancer cell lines were never meth-
ylated in the 114 primary malignancies studied [49]. A
recent large-scale genome-wide study of DNA methyla-
tion re-emphasized the effect of cell culture on the epi-
genome [50]. Using reduced-representation bisulfite
sequencing, Varley and colleagues [50] found that nor-
mal human tissues and primary cell lines form two sep-
arate and robust clades based on genome-wide DNA
methylation patterns. That is, the methylome of primary
cell lines from multiple different tissues more closely re-
sembled each other than the normal tissues from which
they were derived [50]. How and why cell lines accumu-
late CGI methylation in culture is unknown, but in their
seminal paper in 1990, Antequera, Boyes and Bird pro-
posed that the observed CGI hypermethylation was
consistent with a loss of DNA demethylase activity in
culture, 20 years prior to the characterization of arobust mammalian demethylation pathway based on
5hmC/Tet [11].
By studying the establishment of MEFs in culture we
found that adaptation by mammalian cells resulted in a
rapid and comprehensive re-programming of the tran-
scriptome and epigenome, indicative of an altered cell
state. Re-programming involved almost complete loss of
5hmC in cultured cells, consistent with loss of a methyl-
cytosine dioxygenase activity in culture; in the absence
of Tet enzymatic activity, 5hmC lost by dilution during
each round of DNA replication cannot be restored. This
loss was observed genome-wide and was not restricted
to particular genomic compartments, again consistent
with a general loss of Tet-mediated demethylase activity.
In the absence of a demethylase activity, de novo methyla-
tion events cannot be erased and would result in progres-
sive accumulation of methylation at methylation-prone
loci, which over time is likely (perhaps through spreading)
to affect gene expression, imprinting, chromatin structure
and genome stability. Indeed, even at the early time-points
assayed here, we observed increased CGI methylation at
several loci known to be prone to hypermethylation in
cancer, such as the Hox clusters [51,52].
The epigenetic remodeling we observed was paralleled
by extensive gene expression changes in culture. Up-
regulated genes were linked to cell adhesion and extracel-
lular matrix organization, possibly reflecting adaptation
to growth on a two-dimensional plastic surface. How-
ever, a recent study has suggested that these genes are
regulated directly by Tet1 in MEFs [37]. A highly signifi-
cant down-regulation of genes involved in a variety of
epigenetic processes, including nucleosome assembly,
chromatin modification, DNA methylation and DNA
demethylation, were also observed. These included Tet1
and three components of the PRC2 complex, which de-
posits the repressive histone modification H3K27me3,
namely Ezh2, Suz12 and Rbbp4. Tet1 directly interacts
with Suz12 in mouse ES cells, and loss of Suz12 results
in a global loss of 5hmC in mouse ES cells similar in
scale to that reported here [35]. It is tempting to specu-
late that CGIs marked by H3K27me3 are actively main-
tained in an unmethylated state by Tet1 and may thus
be particularly susceptible to aberrant methylation upon
loss of the Tet1 interaction with the PRC2 complex, or
methylcytosine dioxygenase activity in culture.
A 50% reduction in Tet1 gene expression is unlikely to
fully account for the significant global loss of 5hmC ob-
served, particularly as expression of Tet2 and Tet3 were
relatively unchanged in culture. All Tet enzymes require
2-oxoglutarate and vitamin C as cofactors to efficiently
catalyze hydroxylation of canonical 5mC to 5hmC [24].
Most cell culture media do not contain vitamin C, and
several recent studies have shown that addition of vita-
min C increases Tet enzyme activity and 5hmC levels in
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yet substantial recovery of global 5hmC levels upon
addition of 1,000 μM vitamin C during establishment of
MEF cultures. This result suggests that the observed loss
of 5hmC results from both a reduction of Tet1 levels
and general loss of Tet activity due to limiting co-
factors. Significantly, addition of vitamin C to mouse ES
cells resulted in greater Tet-dependent demethylation at
methylated CGIs, resulting in a more blastocyst-like
state in the ES cells [23]. This finding, in combination
with our observations reported here, suggest that
optimization of culture media with regard to enzymatic
co-factors may ameliorate the scale of epigenetic
changes occurring in culture. The identification of suit-
able substrates for culturing cells, probably in three di-
mensions, will also lead to improvements in generating
in vitro equivalents of in vivo cellular morphologies. As
vitamin C is an essential co-factor for a growing list of
enzymes, including the epigenetic modifiers JHDM1B,
KDM3 and KDM4, and regulates hypoxic inducible fac-
tor (HIF)-1 activity through asparagine and proline hy-
droxylases and is also critical to collagen metabolism,
caution may need to be applied when assessing the ef-
fect of vitamin C on individual molecular pathways such
as DNA demethylation [53-55].
Our findings reinforce a growing realization that cell
line models of human diseases, particularly cancer, can
be poor surrogates for many aspects of in vivo biology,
as emphasized in a recent study of multi-drug resistance
genes in ovarian cancer, in which no correlation in ex-
pression was found between primary ovarian cancer
samples and established cancer cell lines [56]. Though
novel, the findings presented here do not address cause
and effect of the observed reprogramming during the
process of adaptation of cells to culture. That is, are the
observed changes driven by epigenome dynamics or is
the epigenome responding to changes in transcription
factor networks? Are the observed gains in 5mC due to
loss of 5hmC or independent of this deficit? A system in
which Tet1 expression can be induced during the
process of adaptation to culture would help to address
some of these questions. It is worth noting that Tet1 can
replace Oct4 to initiate somatic cell reprogramming in
conjunction with Sox2, Klf4, and c-Myc [57]. This re-
quires an active form of the enzyme that results in al-
tered DNA methylation and hydroxymethylation profiles
in the derived pluripotent cells.
Conclusion
Our study demonstrates the utility of using 5hmC profil-
ing as a read-out of cellular state [31]. It is possible that
this type of analysis can be applied to many dynamic sys-
tems, including models for cancer progression [58]. In
conclusion, over 20 years since its initial proposal [11], wepresent the first clear evidence that cell culture-induced
hypermethylation results from loss of a demethylase ac-
tivity, and that the changes induced by cell culture are
far more rapid and widespread than previously thought.
It will be of future interest to determine if these changes
are reversible in novel culturing media [59].
Materials and methods
Establishment of mouse embryonic fibroblast cultures
MEF cultures were established from wild-type B6
13.5 days-post-coitum embryos. The excised uterus
containing the embryos was transferred to a 25 ml uni-
versal tube containing cold phosphate-buffered saline
(PBS)/PS solution (1× PBS and 5% penicillin/strepto-
mycin). The embryo string was transferred to a 10 cm
petri dish containing 5 ml PBS/PS solution and the pla-
centa, membranes, string and organs were discarded.
The head was retained for embryo sexing by PCR ana-
lysis (see below). The resulting material was finely
chopped with a scalpel blade and incubated in 300 μl
trypsin per embryo for 10 minutes at 37°C. The tissue
was further homogenized by repeated (20 times) syrin-
ging (19G needle and 3 ml syringe). After the addition
of 5 ml growth medium (Dulbecco’s modified Eagle
medium, Invitrogen, Paisley, Renfrewshire, UK, catalogue
number 41965-039 15% fetal calf serum (FCS); 5% penicil-
lin/streptomycin; 5% sodium pyruvate solution, Invitrogen
catalogue number S8636; 5% MEM non-essential amino
acid solution, Invitrogen catalogue number M7145),
cells were briefly centrifuged (300 × g for 4 minutes)
and re-suspended in 5 ml growth media and plated onto
a T25 cell culture flask.
Embryos were sexed by PCR as previously published
[60]. Briefly, embryo heads were placed in a 1.5 ml eppen-
dorf tube with 500 μl H2O and boiled for 10 minutes, vor-
texed vigorously and spun for 1 minute at 10,000 × g in a
bench top centrifuge. The resulting supernatant (2.5 μl)
was then used as the template in the PCR amplification
of a fragment of the Ube1X (chromosome X) and Ube1Y
(chromosome Y) genes, using the following primers (5′-3′):
TGGTCTGGACCCAAACGCTGTCCACA and GGCAG
CAGCCATCACATAATCCAGATG. PCR products were
run on a 2.5% agarose gel.
Naïve CD4+ T cell isolation and culture
Naïve CD4+ T cells were isolated from B10.PLxC57BL/6
mice by MACS according to the manufacturer’s instruc-
tions (Miltenyi Biotec, Bergisch Gladbach, North Rhine-
Westphalia, Germany and cells were cultured at a density
of 3 × 106/ml on six-well plates for five days in RPMI
1640 medium supplemented with 2 mM L-glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin, 5 × 10-5 M
2-ME (all from Invitrogen Life Technologies, Paisley,
UK), and 10% FCS (Sigma, Irvine, Scotland For T-cell
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ml in the presence or absence of 10 U/ml rIL-2 (R&D
Systems, Abingdon, Oxfordshire, UK on six-well plates
pre-coated with 2 μg/ml anti-CD3 (clone 145.2C11;
eBioscience, Hatfield, Hertfordshire, UK) plus anti-CD28
(clone 37.51; e-Bioscience).
Cell division analysis: CSFE
Isolated CD4+ T cells were labeled with 5 μM carboxy-
fluorescein diacetate succinimidyl ester (CFSE; Sigma) at
37°C for 20 minutes. Cells were washed in RPMI 1640
supplemented with 10% FCS and cultured as stated
above. At the indicated time-points, cells were har-
vested and stained with anti-CD4-eFluor450 (clone
RM4-5; eBioscience). Flow cytometric data were ac-
quired using a BD LSRFortessa cell analyzer (Becton
Dickinson, Oxford, Oxfordshire, UK and data analyzed
using FlowJo software (Treestar version 3.2.1, Ashland,
Oregon, USA).
Cell cycle analysis: propidium iodide
Cells were sampled at the indicated time-points and
single-cell suspensions were immediately fixed in 2%
paraformaldehyde for 20 minutes at 37°C prior to sur-
face staining with anti-CD4-eFluor450. Cells were then
re-suspended in ice-cold 90% methanol and stored at
-20°C. Cells were washed extensively in PBS containing
2% FCS (Sigma) and stained with propidium iodide
(eBioscience) for 30 minutes at 4°C. Flow cytometric
data were acquired using a BD LSRFortessa cell analyzer
(Becton Dickinson) and data analyzed using FlowJo
software (Treestar version 3.2.1).
DNA immuno-dot-blot
DNA samples were added to denaturation buffer
(0.4 mM NaOH, 10 mM EDTA) and denatured for
10 minutes at 100°C. Samples were rapidly chilled for
5 minutes on wet ice and then applied to a positively
charged nylon membrane under vacuum using a 96-well
Dot Blot Hybridisation Manifold (Harvard Apparatus
Limited, Holliston, MA, USA The membrane was washed
twice in 2× SSC buffer, UV-crosslinked, and dried for 1 h
at 70°C. Duplicate membranes were probed with anti-
bodies specific to 5mC (Eurogentec, Seraing, Liege,
Belgium; dilution factor 1:2,000) and 5hmC (Active
Motif, Carlsbad, CA, USA dilution factor 1:8,000). To
control for loading, duplicate membranes were either
probed with a rabbit poly-clonal antibody raised against
single-stranded DNA (Demeditec Diagnostics, Kiel,
Schleswig-Holstein, Germany) or stained with methylene
blue. Subsequently, membranes were probed with either
a rabbit (α-5hmC and α-ssDNA membranes) or mouse
(α-5mC membranes) IgG antibody conjugated to horse-
radish peroxidase. Following treatment with enhancedchemiluminescence substrate, membranes were scanned
on an ImageQuant LAS 4000 (GE Healthcare, Little
Chalfont, Buckinghamshire, UK) imaging station. Spot
intensity was quantified using ImageJ image processing
and analysis software (NIH).
5-Methylcytosine and 5-hydroxymethylcytosinse
immunodetection in fibroblasts
Immunofluorescence staining of MEFS was carried out
as previously described [9,33] with 5mC mouse monoclo-
nal (Eurogenentec) and 5hmC polyclonal (Active Motif)
antibodies.
Arid5b immunodetection in fibroblasts
Embryonic fibroblast cells or primary embryonic fibro-
blasts (CD1 and C57BL/6) on glass coverslips coated
with gelatin were stained using standard immunocyto-
chemistry protocols. Cells were fixed with 4% parafor-
maldehyde for 10 minutes at room temperature and
incubated with anti Arid5b antibody (Novus Biologicals,
Littleton, Colorado, USA) followed by a 1 hour incuba-
tion with Alexafluor 488 secondary antibody (Life Tech-
nologies, Life Technologies, Paisley, Renfrewshire, UK
prior to staining with DAPI (4′,6-diamidino-2-phenylindole).
Imaging was done using a Zeiss Axioskop 2 microscope
and Zeiss objectives.
Immunoprecipitation and genomic mapping of 5mC- and
5hmC-containing DNA
Genomic DNA (5hmC-IP; 2.5 μg in 450 μl of TE), soni-
cated to yield a fragment distribution of 300 to 1,000 bp,
was denatured by incubation for 10 minutes at 100°C.
Samples were rapidly chilled on wet ice. At this point,
45 μl (10%) of denatured sample was removed and saved
as input, and 45 μl of 10× immunoprecipitation (IP buffer
(100 mM Na-phosphate at pH 7.0 (mono and dibasic),
1.4 M NaCl, 0.5% Triton X-100) and 1 μg of α-5hmC
(Active Motif, catalog number 39769) antibody were
added to the remaining sample. Samples were incubated
overnight at 4°C with gentle agitation. Then, 40 μl of
magnetic beads (Dynabeads Protein G; Invitrogen) in 1×
IP buffer was added to each sample to allow magnetic
separation of the antibody from the unbound DNA
using a magnetic tube rack. Samples were incubated for
1 h at 4°C with gentle agitation. Beads were collected
with a magnetic rack and washed with 1 ml of 1× IP
buffer for 10 minutes at room temperature with gentle
agitation; washing was repeated three times. Beads were
collected with a magnetic rack and resuspended in
250 μl of digestion buffer (50 mM Tris at pH 8.0,
10 mM EDTA, 0.5% SDS) followed by addition of 10 μl
of proteinase K (20 mg/ml; Roche Applied Science,
Penzberg, Upper Bavaria, Germany) and incubation over-
night at 52°C with constant shaking (800 rpm). Finally,
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purified from the remaining sample using a QIAquick
PCR Purification Kit (QIAGEN, Hilden, North Rhine-
Westphalia, Germany eluting in a final volume of 47 μl of
dH2O. Inputs were also purified using a QIAquick PCR
Purification Kit and eluted in 47 μl of dH2O. Subse-
quently, 10 ng of input and IP DNA was subjected to
whole genome amplification using the GenomePlex
Complete Whole Genome Amplification Kit (Sigma-
Aldrich, St. Louis, Missouri, USA as per the manufacturer’s
instructions. Amplified DNA was run on a 1.2% agarose
gel to confirm consistency of fragment size between sam-
ples. Subsequently, amplified DNA samples were Cy5 (IP)
or Cy3 (input) labeled by random priming using the Dual-
Color DNA Labeling Kit (NimbleGen (Hoffmann-La
Roche), Basel, Basel-Stadt, Switzerland Labeled samples
were applied to NimbleGen mouse (mm8) whole genome
tiling array (covering chromosomes 14 to Y) and hybrid-
ized overnight at 42°C. Slides were washed and scanned as
per the NimbleGen protocol.
Analysis of microarray data
All analysis of NimbleGen microarray data was per-
formed using custom-written scripts implemented in the
statistical programming language R. First, each array was
subjected to locally weighted scatterplot smoothing (Loess
normalization)). The data were then smoothed using a
running median in a sliding window of seven probes
(approximately 1,700 bp). A peak of 5hmC was defined
as any region of five consecutive probes in which at least
four probes had an enrichment value greater than the
90th percentile. This definition of a peak resulted in a
false discovery rate of <0.01. Hierarchical clustering was
performed using the ‘hclust’ function in the R program-
ming language; a distance matrix was computed for
each data set using Euclidean distance; subsequently
samples were clustered using Ward’s minimum variance
agglomeration method. Autocorrelation analysis was
carried out using the ‘acf ’ function of the R stats pack-
age. All R scripts are available upon request (to CEN).
hMeDIP-Seq
hmeDIP-Seq was performed as previously described [61].
Briefly, DNA was sonicated to yield fragmented DNA with
a modal size of 150 bp. Following end-repair and A-tailing,
Illumina TruSeq adaptors were added to the resulting DNA
according to the manufacturer’s instructions. The adaptor
ligated DNA was then subjected to hMeDIP as outlined
above. The resulting input and hMeDIP samples were
PCR amplified for 15 cycles using single-end Illumina
PCR primers. Finally, libraries were size selected by agar-
ose gel electrophoresis. All DNA purification steps were
carried out using Agencourt AMPure Beads (Beckman
Coulter, Brea, California, USA), and DNA quality, quantityand size were tested after every step on an Agilent
Bioanalyser using High Sensitivity DNA chips (Agilent
Technologies, Santa Clara, California, USA Samples
were subjected to single-end sequencing on the Illumina
GAIIx platform. Sequencing was carried out at the
Genomics Core, Albert Einstein College of Medicine,
New York.
Analysis of hMeDIP-Seq data
hMeDIP-seq reads were generated on an Illumina Genome
Analyser IIx and mapped to the mm9 build of the
mouse genome using the bowtie short read aligner [8].
Where a read mapped to a number of potential loca-
tions, only the best hit was retained (in terms of the
number of mismatches and their qualities; as specified
by the bowtie ‘-best’ parameter).
BEDTools [9] was used to count mapped reads that over-
lap genomic windows, calculate coverage, and normalize
data to total read count. The MACS program was used
for peak calling (default parameters).
Analysis of CMS-Seq data
Normalized (reads per million) CMS-Seq data for mouse
naïve CD4+ T cells and their in vitro derived T-helper
type 1 (Th1) counterparts were downloaded from the GEO
(accession GSE59212) [41]. Peaks of 5hmC (CMS) enrich-
ment were determined using MACS ChIP-Seq peak-calling
software with default parameters. Gene-body and promoter
enrichment was defined as median coverage across the en-
tire genic region. The BEDtools suite of software was used
to map enriched peaks to different genic compartments
based on mouse genome version 9 (mm9) refGene coordi-
nates [62]. Genome track images were modified from
the Integrated Genome Viewer software [63].
Analysis of MBD-Seq data
Normalized (reads per million) MBD-Seq data for mouse
naïve CD4+ T cells and their in vitro derived T-helper
type 1 (Th1) counterparts were downloaded from the
GEO (accession GSE25689) [40]. Peaks of methyl-CpG
enrichment were determined using MACS ChIP-Seq
peak-calling software with default parameters. Gene-
body and promoter enrichment was defined as median
coverage across the entire genic region. Promoters and
genes with less than five reads in both samples were ex-
cluded. The BEDtools suite of software was used to map
enriched peaks to different genic compartments based
on mouse genome version 9 (mm9) refGene coordinates
[62]. Genome track images were modified from the Inte-
grated Genome Viewer software [63].
GLIB enrichment of 5hmC
GLIB enrichment was performed using the Hydroxymethyl
Collector Kit (Active Motif). Genomic DNA was sonicated
Nestor et al. Genome Biology  (2015) 16:11 Page 15 of 17(Bioruptor; Diagenode, Liege, Seraing, Belgium to produce
DNA fragments ranging in size from 200 to 1,000 bp,
with a modal fragment size of 400 bp. Fragmented DNA
(1 μg) was glucosylated by incubation with dUTP
containing a modified azide glucose group and 20U
β-glucosyltransferase for 1 h at 37°C. The modified
glucose group was then biotinylated and fragments of
DNA containing modified biotin-azide-glucose-5hmC
were purified with magnetic streptavidin beads. DNA
was then passed through a DNA purification column
and eluted in elution buffer prior to qPCR. All reagents
employed were supplied with the Hydroxymethyl Collector
Kit (Active Motif).
DNA and RNA extraction and quantitative reverse
transcriptase PCR
DNA was isolated from cells and tissues using the QIA-
GEN DNeasy Mini Kit. Genomic DNA was isolated from
mammalian cells using the following method. The cell
pellet was resuspended in 200 μl lysis buffer (20 mM
Tris pH8, 4 mM EDTA, 20 mM NaCl, 1% SDS). Protein-
ase K (20 μl, 20 mg/ml; Roche Applied Science) was
added and samples incubated overnight at 55°C. The sec-
ond day samples were cooled down to 37°C and treated
with 1 μl RNase cocktail (Ambion; AM2286) and incu-
bated at 37°C for 30 minutes. Genomic DNA was isolated
by standard phenol/chloroform extraction. RNA was ex-
tracted from cell lines using TRIzol reagent (Invitrogen)
or an RNeasy Mini kit (QIAGEN) according to the manu-
facturers’ instructions. A Superscript II Reverse transcript-
ase kit (Invitrogen) was used to make complementary
DNA from 500 ng of total RNA. All qRT-PCRs were
carried out in a LightCycler 480 Real-Time PCR System
(Roche Applied Science). Primer sequences are given in
Table S2 in Additional file 1.
Expression microarray analysis
Total RNA was isolated from cells using TRIzol (Invitrogen).
RNA integrity (RIN) was assessed using an Agilent 2100
Bioanalyzer (samples used had RIN score of ≥8.0). RNA
was amplified and biotinylated using an Illumina Total-
Prep RNA Amplification Kit and subsequently hybridized
to Illumina mouse WG-6 Expression BeadChips. Array
processing was performed at the Wellcome Trust Clinical
Research Facility in Edinburgh.
Arrays were background subtracted and quantile
normalized using the lumi package of the R program-
ming language. Differential expression was determined
by paired t-test with correction for multiple testing
(Benjamini and Hohchberg).
Luminometric methylation assay
LUMA combines differential DNA cleavage by methylation-
sensitive restriction enzymes with pyrosequencing todetermine genome-wide DNA methylation levels at CCGG
sites and has been described in detail elsewhere [64].
Bisulfite sequencing
Genomic DNA (500 ng) was bisulfite treated using an
EZ DNA Methylation-Lightning kit (Zymo Research,
Irvine, California, USA according to the manufacturer’s
instructions. Bisulfite primers were designed using the
‘Bisearch’ algorithm [65] and are shown in Table S1 in
Additional file 1. Products were amplified by two rounds
of PCR, the second using nested primers, then resolved
by agarose gel electrophoresis. A negative control reac-
tion containing dH20 in place of bisulfite converted
DNA was used for each set of reactions. Products were
gel extracted, cloned into pGEM T Easy vector (Promega,
Fitchburg, Wisconsin, USA and transformed into Library
Efficiency DH5α bacteria (Invitrogen). Blue/white screen-
ing was performed using X-gal (Sigma). Plasmid DNA
from individual colonies was isolated by miniprep and
sequenced using SP6 and T7 sequencing primer using
the dideoxy sequencing method. The sequences were
imported into the ‘BioEdit’ program [66] and aligned to
a reference sequence for the region, created by in silico
bisulfite treatment, using the ‘ClustalW’ inbuilt pro-
gram. Clones with identical sequences were removed
due to the possibility of PCR bias. Clones with <95%
conversion rate of C to T were excluded. The methyla-
tion status of each CpG dinucleotide from each bacterial
clone was assessed by the presence or absence of C to T
conversion in the PCR product, and visualized using
‘QUMA’ online program [2,67] The overall percentage
CpG methylation was calculated for each region.
Data access
All data have been deposited in ArrayExpress at the
European Bioinformatics Institute under the acces-
sions E-MTAB-3172, E-MTAB-3176, E-MTAB-3177,
and E-MTAB-3183 [68].
Additional file
Additional file 1: A PDF document containing all supplementary data
for this paper. Included are 12 supplemental figures (Figures S1 to S12)
and four supplemental tables (Tables S1 to S4).
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